Original Article

Predicting survival of patients with hypocellular myelodysplastic syndrome†

Development of a disease-specific prognostic score system

  1. Wei-Gang Tong MD1,
  2. Alfonso Quintás-Cardama MD1,
  3. Tapan Kadia MD1,
  4. Gautam Borthakur MD1,
  5. Elias Jabbour MD1,
  6. Farhad Ravandi MD1,
  7. Stefan Faderl MD1,
  8. William Wierda MD1,
  9. Sherry Pierce MD1,
  10. Jianqin Shan MD1,
  11. Carlos Bueso-Ramos MD2,
  12. Hagop Kantarjian MD1,
  13. Guillermo Garcia-Manero MD1,‡,*

Article first published online: 17 JAN 2012

DOI: 10.1002/cncr.27420

Issue

Cancer

Cancer

Volume 118, Issue 18, pages 4462–4470, 15 September 2012

Additional Information

How to Cite

Tong, W.-G., Quintás-Cardama, A., Kadia, T., Borthakur, G., Jabbour, E., Ravandi, F., Faderl, S., Wierda, W., Pierce, S., Shan, J., Bueso-Ramos, C., Kantarjian, H. and Garcia-Manero, G. (2012), Predicting survival of patients with hypocellular myelodysplastic syndrome. Cancer, 118: 4462–4470. doi: 10.1002/cncr.27420

Author Information

  1. 1

    Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas

  2. 2

    Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas

  1. ‡

    Fax: (713) 794-4297

*Department of Leukemia, The University of Texas MD Anderson Cancer Center, Box 428, Houston, TX 77030

  1. †

    W.-G.T. and A.Q.-C. wrote the paper and analyzed the data. T.K., G.B., E.J., F.R., S.F., W.W., and H.K. contributed patients, helped write the paper, and analyzed the data. S.P. and J.S. performed part of the statistical analysis and helped write the paper. C.B.-R. was the hematopathologist who reviewed cases. G.G.-M. designed the study, analyzed data, contributed patients, and wrote the paper.

  2. ‡

    Fax: (713) 794-4297

Publication History

  1. Issue published online: 5 SEP 2012
  2. Article first published online: 17 JAN 2012
  3. Manuscript Accepted: 8 NOV 2011
  4. Manuscript Revised: 21 SEP 2011
  5. Manuscript Received: 14 JUL 2011

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (410K)

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Emanuela Boveri, Giorgio Croci, Umberto Gianelli, Marcello Gambacorta, Giuseppe Isimbaldi, Alessia Moro, Andrea Gianatti, Marco Ungari, Enrica Morra, Histopathological and immunohistochemical evaluation of bone marrow biopsy in myelodysplastic syndromes, International Journal of Hematologic Oncology, 2013, 2, 3, 219

    CrossRef

  2. 2
    Drorit Merkel, Kalman Filanovsky, Anat Gafter-Gvili, Liat Vidal, Ariel Aviv, Moshe E. Gatt, Itay Silbershatz, Yair Herishanu, Ariela Arad, Tamar Tadmor, Najib Dally, Anatoly Nemets, Ory Rouvio, Aharon Ronson, Katrin Herzog-Tzarfati, Luiza Akria, Andrei Braester, Ilana Hellmann, Shay Yeganeh, Arnon Nagler, Ronit Leiba, Moshe Mittelman, Yishai Ofran, Predicting infections in high-risk patients with myelodysplastic syndrome/acute myeloid leukemia treated with azacitidine: Aretrospective multicenter study, American Journal of Hematology, 2013, 88, 2
    Direct Link:
  3. 3
    H. Signorelli, DO, Predicting Survival of Patients With Hypocellular Myelodysplastic Syndrome: Development of a Disease-Specific Prognostic Score System, Yearbook of Pathology and Laboratory Medicine, 2013, 2013, 372

    CrossRef

  4. 4
    Paolo Bernasconi, Catherine Klersy, Marina Boni, Paola Maria Cavigliano, Irene Dambruoso, Rita Zappatore, Validation of the new comprehensive cytogenetic scoring system (NCCSS) on 630 consecutive de novo MDS patients from a single institution, American Journal of Hematology, 2013, 88, 2
    Direct Link:
  5. You have free access to this content5
    Guillermo Garcia-Manero, Myelodysplastic syndromes: 2012 update on diagnosis, risk-stratification, and management, American Journal of Hematology, 2012, 87, 7
    Direct Link:
  6. 6
    Ulrich Germing, Andrea Kündgen, Prognostic scoring systems in MDS, Leukemia Research, 2012, 36, 12, 1463

    CrossRef

View Full Article (HTML) Get PDF (410K)